Search for the latest updates on diabetes
News
Poxel Announces Positive Top Line Results for Its Antidiabetic Agent Imeglimin in a Phase 2b Dose-Ranging Trial Business Wire via Yahoo! Finance - 11 minutes
LYON, France--(BUSINESS WIRE)-- Poxel SA today announced that Imeglimin, a novel compound in development to treat Type 2 Diabetes, ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment